The 233 significant medication pairs, consisting of 69 unique medications, are visualized as a hairball network diagram where each vertex indicates a medication (69 unique medications resulting in 69 vertices). Each of the vertices is linked via an edge if two medications are medication pairs with a high AKI correlation (233 significant medication pairs resulting in 233 edges). The width of the edges represents the administration frequency (0 − 50; 50 − 500; >500). The color of the edges shows the strength of Pearson similarity coefficients for the medication pairs (correlation coefficient of >0.08 is red, 0.07−0.08 is orange, and 0.07is grey). The size of the vertices represents the administration frequency of the single medications (0 − 2...
<p>A network graph to visualize association rules between symptoms (cough, overextertion/fatigue, in...
<p>Total number of entities and relationships present in the largest network generated for a list we...
Polypharmacy is the combined use of multiple drugs, widely adopted in medicine to treat patients tha...
We identified six communities of medication clusters (from a to f), where each cluster is visualized...
<p>The DT network was generated using known FDA-approved small molecule DT interactions. The size of...
<p>Numbers represent the number of studies that reported a direct comparison between each pair of tr...
<p>Solid lines represent direct comparisons within randomised trials. Nodes in blue represent contro...
<p>Each node presents a drug, and two nodes are linked if their similarity (in terms of polypharmaco...
<p>Drugs and targets are presented by red circle and blue triangle, respectively. Drug-target intera...
<p>Thicker edges represent stronger absolute correlations. Left: true network of partial correlation...
The symmetric correlation matrix was created using the “corrplot” R package. The colours represent t...
<p>The entire workflow includes five steps: (i) collection of known drug-target interaction data and...
<p>Network graph of the correlational relationships between 55 items (symptoms) of the CPRS, which f...
<p>The loops (grey lines) with corresponding numbers (1, 2, 3) show the subgroups, which were direct...
<p>The legend is common for figures A, B and D: The correlation network represents features that are...
<p>A network graph to visualize association rules between symptoms (cough, overextertion/fatigue, in...
<p>Total number of entities and relationships present in the largest network generated for a list we...
Polypharmacy is the combined use of multiple drugs, widely adopted in medicine to treat patients tha...
We identified six communities of medication clusters (from a to f), where each cluster is visualized...
<p>The DT network was generated using known FDA-approved small molecule DT interactions. The size of...
<p>Numbers represent the number of studies that reported a direct comparison between each pair of tr...
<p>Solid lines represent direct comparisons within randomised trials. Nodes in blue represent contro...
<p>Each node presents a drug, and two nodes are linked if their similarity (in terms of polypharmaco...
<p>Drugs and targets are presented by red circle and blue triangle, respectively. Drug-target intera...
<p>Thicker edges represent stronger absolute correlations. Left: true network of partial correlation...
The symmetric correlation matrix was created using the “corrplot” R package. The colours represent t...
<p>The entire workflow includes five steps: (i) collection of known drug-target interaction data and...
<p>Network graph of the correlational relationships between 55 items (symptoms) of the CPRS, which f...
<p>The loops (grey lines) with corresponding numbers (1, 2, 3) show the subgroups, which were direct...
<p>The legend is common for figures A, B and D: The correlation network represents features that are...
<p>A network graph to visualize association rules between symptoms (cough, overextertion/fatigue, in...
<p>Total number of entities and relationships present in the largest network generated for a list we...
Polypharmacy is the combined use of multiple drugs, widely adopted in medicine to treat patients tha...